⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 2024

Supplementary Figure S2 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy

Elisa Yaniz‐Galende Qinghe Zeng Juan F. Bejar-Grau Christophe Klein Félix Blanc‐Durand Audrey Le Formal Éric Pujade-Lauraine Laure Chardin Elodie Edmond Virginie Marty Isabelle Ray‐Coquard Florence Joly Gwénaël Ferron Patricia Pautier Dominique Berton-Rigaud Alain Lortholary Nadine Dohollou Christophe Desauw Michel Fabbro Emmanuelle Malaurie Nathalie Bonichon-Lamaichhane Diana Bello Roufai Justine Gantzer Étienne Rouleau Catherine Genestie Alexandra Léary

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Change in GrzB expression min paired samples post-NACT

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yaniz‐Galende et al. (2024) studied this question.

synapsesocial.com/papers/68e62195b6db6435875b3720 https://doi.org/10.1158/1078-0432.26134450

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S2 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy2024
2Supplementary Figure S3 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy2024
3Supplementary Figure S3 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy2024
4Supplementary Figure S4 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy2024
5Supplementary Figure S4 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy2024

More related papers

Supplementary Figure S1 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy2024
Figure S2 from Analysis of tumor microenvironment changes after neoadjuvant chemotherapy with or without bevacizumab in advanced ovarian cancer (GEICO-89T/MINOVA study).2024
Figure S3 from Analysis of tumor microenvironment changes after neoadjuvant chemotherapy with or without bevacizumab in advanced ovarian cancer (GEICO-89T/MINOVA study).2024